Kinecta Federal Credit Union Voted South Bay’s Best Credit Union According to Easy Reader’s “Best of the Beach” Poll
Easy Reader readers vote Kinecta as the South Bay’s Best Credit Union for the fourth year in a row MANHATTAN BEACH, Calif., March 28, 2024 /PRNewswire/ — For the fourth year in a row, Kinecta Federal Credit Union was voted Best Credit Union in the South Bay in Easy Reader’s 2024
GRAMMY® AWARD-WINNING ARTIST 2 CHAINZ HEADLINES WITH SPECIAL GUESTS JUVENILE, TRAVIS PORTER, AND THE RENOWNED DJ SKRIBBLE
THE CITY OF FRISCO, TEXAS HOSTS ITS FIRST CINCO DE MAYO TACOS & TEQUILA FESTIVAL FRISCO – THE LARGEST MUSIC AND FOOD FESTIVAL IN THE CITY’S HISTORY! FRISCO, Texas, March 28, 2024 /PRNewswire/ — As the fastest-growing city in the country, Frisco, Texas, is set to host its inaug
TAYLOR DEVICES ANNOUNCES THIRD QUARTER AND NINE-MONTH RESULTS INCLUDING RECORD HIGH SALES AND EARNINGS
NORTH TONAWANDA, N.Y., March 28, 2024 /PRNewswire/ — Taylor Devices, Inc. (NASDAQ SmallCap: “TAYD”) announced today that it had 3rd quarter sales of $12,254,093, up 24% from last year’s 3rd quarter sales of $9,891,272 while sales for the 1st nine months were $32,517,596, up 1
Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments
BOSTON, March 28, 2024 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency (DARPA) to achieve DARPA&#
Ionis to hold olezarsen Phase 3 data webcast
Webcast scheduled for Monday, April 8 at 10:00 a.m. Eastern Time CARLSBAD, Calif., March 28, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Monday, April 8th at 10:00 a.m. Eastern Time to discuss the olezarsen Phase 3 Balance
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD
A single ABBV-RGX-314 gene therapy treatment has the potential to become a new standard-of-care option among anti-VEGF treatments by sustaining vision health long term and overcoming the clinical challenges of managing wet AMD due to the treatment burden of chronic anti-VEGF injectionsPatients who r
Nested Therapeutics to Present Preclinical Data for NST-628, a Novel Pan-RAF/MEK Molecular Glue, in the New Drugs on the Horizon Series at 2024 AACR Annual Meeting
CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that preclinical data from its lead program, NST-628, will be featured in an oral presentati
MESCIUS inc. Launches ActiveReports .NET v18
PITTSBURGH, March 28, 2024 /PRNewswire/ — MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the release of ActiveReports. NET v18. This major release includes exciting new features and improvements to the ActiveReports ecosystem. Act
/R E M I N D E R — Media Advisory – Deputy Prime Minister’s itinerary for Thursday, March 28, 2024/
OTTAWA, ON, March 27, 2024 /CNW/ – Note: All times local. Winnipeg, Manitoba 11:00 a.m. The Deputy Prime Minister will tour a college and make a child care infrastructure announcement in advance of the 2024 federal budget. The Minister of Northern Affairs, Minister responsible for Prairies Ec
Boston Solar Commercial Division Completes Solar Installation for Twin Solar Systems at Framingham, MA Apartment Complex
WOBURN, Mass., March 28, 2024 /PRNewswire/ — SinglePoint Inc (CBOE: SING) (“SinglePoint” or “the Company”) subsidiary Boston Solar, a proud partner of the Boston Red Sox and a leading provider of solar energy solutions, proudly announces their transformative solar inst